Rubicon Research Ltd.

NSE: RUBICON | BSE: 544578 | ISIN: INE506V01022 | Industry: Pharmaceuticals
| Expensive Performer
1386.3000 6.70 (0.49%)
NSE Jul 08, 2026 15:31 PM
Volume: 243.3K
 

logo
Rubicon Research Ltd.
13 Nov 2025
1386.30
0.49%

Outperformance across metrics; stellar start to the post-IPO phase

buy
by Motilal Oswal
Target: 780
Motilal Oswal
Rubicon Research (Rubicon) delivered better-than-expected performance, with a 7%/18%/21% beat on revenue/EBITDA/PAT for the quarter.
 
Rubicon Research Ltd. is trading above all available SMAs
More from Rubicon Research Ltd.
Recommended
Market closes lower after Donald Trump says Iran truce is 'over'
Trendlyne Marketwatch | 08 Jul 2026, 03:58PM
India's EV market grows beyond the early winners
The Baseline | 07 Jul 2026, 05:53PM
Primary market focus turns to listings, with eight companies set to debut
| 06 Jul 2026